Mandate

Vinge advises Capio in connection with acquisition of Scanloc

September 01, 2016

Scanloc conducts operations relating to specialist care within eye disorders at clinics situated in Gothenburg and Kungsbacka. The company’s customers primarily consist of the Västra Götaland and Halland County Councils. Scanloc has 35 employees and will be part of Capio Medocular. Closing is scheduled for 30 September and is conditional upon the customary closing conditions from the salient public authorities.

Vinge’s team consisted of responsible partner Anders Strid together with, among others, Frida Bäckergren (project manager), Frida Mattsson (employment), Victor Ericsson (tax) and Gabriella Fossum (public procurement).

Related

Vinge advises Altor on its public offer for Sleep Cycle

Snark BidCo, a company controlled by Altor Fund V (No. 1) and Altor Fund V (No. 2) announced a public offer to the shareholders of Sleep Cycle AB to tender all their shares to Snark BidCo. The shares in Sleep Cycle are admitted to trading on Nasdaq Stockholm. After the end of the extended acceptance period, Snark BidCo controls approximately 79.2 percent of the share capital and votes in Sleep Cycle. The total value of the offer was approximately SEK 497 million.
August 07, 2026

Vinge advises SEB Kort in connection with a cross-border merger with AirPlus

Vinge advised SEB Kort in connection with a cross-border merger whereby the subsidiary AirPlus has been absorbed into SEB Kort.
August 06, 2026

Vinge advises Altor- and Stena-owned Gunnebo in connection with the divestment of Gunnebo Entrance Control AB to ASSA Abloy

Vinge has advised Gunnebo in connection with its divestment of Gunnebo Entrance Control AB to ASSA Abloy.
August 04, 2026